Concepedia

Publication | Open Access

Podoplanin: A Novel Marker for Oral Cancer Risk in Patients With Oral Premalignancy

DOIFull Paper Access

209

Citations

22

References

2008

Year

Hidetoshi Kawaguchi, Adel K. El‐Naggar, Vali Papadimitrakopoulou, Hening Ren, You-Hong Fan, Lei Feng, J. Jack Lee, Edward Kim, Waun Ki Hong, Scott M. Lippman,
Journal of Clinical Oncology

Abstract

Podoplanin is frequently expressed in OPL. Together with histology, podoplanin may serve as a powerful biomarker to predict the risk for oral cancer development in patients with OPL.

References

YearCitations

Page 1